111Category: | Pharmaceuticals and Biochemicals/Central nervous system depressants and stimulants |
|
|
CAS NO: | 15676-16-1 | ||
EC NO: | 239-753-7 | ||
Molecular Formula: | C15H24N3O4S | ||
Molecular Weight: | 342.4332 | ||
Specification: | |||
InChI: | InChI=1/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/p+1/t11-/m1/s1 | ||
Uses: | Antipsychotic, antidepressant, antiemetic, gastric secretory inhibitor, neuroleptic | ||
Synonyms: | SULPIRIDE;5-(aminosufonyl)-n-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide;N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide;(RS)-(+/-)-SULPIRIDE;(RS)-(+/-)-5-AMINOSULFONYL-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2-METHOXYBENZAMIDE;(+/-)-SULPIRIDE;(+/-)-N-1-(ETHYLPYRROLIDIN-2-YLMETHYL)-2-METHOXY-5-SULFAMOYLBENZAMIDE;[+/-]-N-1-[ETHYLPYRROLIDIN-2-YLMETHYL]-2-METHOXY-5-SULFAMOYLBENZAMIDE;Abilit;Aiglonyl;N-[(1-ethylpyrrolidin-3-yl)methyl]-2-methoxy-5-sulfamoylbenzamide;(2S)-1-ethyl-2-({[(2-methoxy-5-sulfamoylphenyl)carbonyl]amino}methyl)pyrrolidinium;(2R)-1-ethyl-2-({[(2-methoxy-5-sulfamoylphenyl)carbonyl]amino}methyl)pyrrolidinium;N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoyl-benzamide; | ||
Molecular Structure: |